Recap: ProPhase Labs Q2 Earnings-To The Moon - Tiger Brokers Online Investing Community - To The Moon

40
1
Favorite

Recap: ProPhase Labs Q2 Earnings

Benzinga2021-08-13

Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.

Revenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

ProPhase Labs hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Aug 13, 2021

Time: 11:00 AM

ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs

Price Action

Company's 52-week high was at $16.04

52-week low: $2.25

Price action over last quarter: Up 16.35%

Company Overview

ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

40

Report

Comment（1）

Siong15
·2021-08-13
What to do?
Reply
Like
Report

Most Discussed

7x24

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2159292219?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-13 20:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2159292219","market":"us","top_or_hot":-1,"title":"Recap: ProPhase Labs Q2 Earnings","media":"Benzinga","content":"<p>Shares of <b><a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a></b> (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.</p>\n<h2>Quarterly Results</h2>\n<p>Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.</p>\n<p>Revenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.</p>\n<h2>Outlook</h2>\n<p>Earnings guidance hasn't been issued by the company for now.</p>\n<p>ProPhase Labs hasn't issued any revenue guidance for the time being.</p>\n<h2>Conference Call Details</h2>\n<p>Date: Aug 13, 2021</p>\n<p>Time: 11:00 AM</p>\n<p>ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs</p>\n<h2>Price Action</h2>\n<p>Company's 52-week high was at $16.04</p>\n<p>52-week low: $2.25</p>\n<p>Price action over last quarter: Up 16.35%</p>\n<h2>Company Overview</h2>\n<p>ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Recap: ProPhase Labs Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRecap: ProPhase Labs Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n2021-08-13 20:36 北京时间&nbsp;&nbsp;&nbsp;<strong>Benzinga</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\nQuarterly Results\nEarnings per share were down 1000.00% over the past year to ($0.09), ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRPH","symbol_name":"ProPhase Labs","start_time":0,"source_url":null,"article_id":"2159292219","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2159292219","pubTimestamp":1628858195,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" \n\nShares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\n\nQuarterly Results\n\nEarnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PRPH":"ProPhase Labs"},"translate_title":"回顾：前期实验室第二季度收益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRPH":0.9},"content_text":"Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\nQuarterly Results\nEarnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.\nRevenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.\nOutlook\nEarnings guidance hasn't been issued by the company for now.\nProPhase Labs hasn't issued any revenue guidance for the time being.\nConference Call Details\nDate: Aug 13, 2021\nTime: 11:00 AM\nET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs\nPrice Action\nCompany's 52-week high was at $16.04\n52-week low: $2.25\nPrice action over last quarter: Up 16.35%\nCompany Overview\nProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":897083355,"gmtCreate":1628863033677,"gmtModify":1676529878913,"author":{"id":"3564724712567045","authorId":"3564724712567045","name":"Siong15","avatar":"https://static.tigerbbs.com/731e68720f172a6444f3a731636b5000","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3564724712567045","authorIdStr":"3564724712567045"},"htmlText":"What to do?","listText":"What to do?","text":"What to do?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897083355","repostId":2159292219,"repostType":4,"repost":{"id":"2159292219","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628858195,"share":"https://ttm.financial/m/news/2159292219?lang=&edition=fundamental","pubTime":"2021-08-13 20:36","market":"us","language":"en","title":"Recap: ProPhase Labs Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2159292219","media":"Benzinga","summary":" \n\nShares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\n\nQuarterly Results\n\nEarnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.","content":"<p>Shares of <b><a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a></b> (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.</p>\n<h2>Quarterly Results</h2>\n<p>Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.</p>\n<p>Revenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.</p>\n<h2>Outlook</h2>\n<p>Earnings guidance hasn't been issued by the company for now.</p>\n<p>ProPhase Labs hasn't issued any revenue guidance for the time being.</p>\n<h2>Conference Call Details</h2>\n<p>Date: Aug 13, 2021</p>\n<p>Time: 11:00 AM</p>\n<p>ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs</p>\n<h2>Price Action</h2>\n<p>Company's 52-week high was at $16.04</p>\n<p>52-week low: $2.25</p>\n<p>Price action over last quarter: Up 16.35%</p>\n<h2>Company Overview</h2>\n<p>ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Recap: ProPhase Labs Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRecap: ProPhase Labs Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-13 20:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b><a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a></b> (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.</p>\n<h2>Quarterly Results</h2>\n<p>Earnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.</p>\n<p>Revenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.</p>\n<h2>Outlook</h2>\n<p>Earnings guidance hasn't been issued by the company for now.</p>\n<p>ProPhase Labs hasn't issued any revenue guidance for the time being.</p>\n<h2>Conference Call Details</h2>\n<p>Date: Aug 13, 2021</p>\n<p>Time: 11:00 AM</p>\n<p>ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs</p>\n<h2>Price Action</h2>\n<p>Company's 52-week high was at $16.04</p>\n<p>52-week low: $2.25</p>\n<p>Price action over last quarter: Up 16.35%</p>\n<h2>Company Overview</h2>\n<p>ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRPH":"ProPhase Labs"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159292219","content_text":"Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results.\nQuarterly Results\nEarnings per share were down 1000.00% over the past year to ($0.09), which missed the estimate of $0.33.\nRevenue of $9,142,000 rose by 152.33% from the same period last year, which missed the estimate of $15,650,000.\nOutlook\nEarnings guidance hasn't been issued by the company for now.\nProPhase Labs hasn't issued any revenue guidance for the time being.\nConference Call Details\nDate: Aug 13, 2021\nTime: 11:00 AM\nET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs\nPrice Action\nCompany's 52-week high was at $16.04\n52-week low: $2.25\nPrice action over last quarter: Up 16.35%\nCompany Overview\nProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company's operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":40,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}